Semaglutide is a mimic of the natural hormone GLP-1 and belongs to the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) class. The body’s intestines release GLP-1 in response to food consumption, aiding in managing blood sugar levels by promoting insulin release and diminishing glucagon secretion. Administered via injection, Semaglutide serves as a pharmaceutical option for patients.